CPXRX
Price
$16.60
Change
+$0.08 (+0.48%)
Updated
Aug 21 closing price
Net Assets
2.51B
FSMAX
Price
$117.72
Change
-$1.39 (-1.17%)
Updated
Aug 20 closing price
Net Assets
40.08B
Interact to see
Advertisement

CPXRX vs FSMAX

CPXRX vs FSMAX Comparison Chart in %
View a ticker or compare two or three
VS
CPXRX vs. FSMAX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CPXRX is a Hold and FSMAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 40.1B vs. CPXRX (2.51B). CPXRX pays higher dividends than FSMAX: CPXRX (1.11) vs FSMAX (0.50). CPXRX was incepted earlier than FSMAX: CPXRX (14 years) vs FSMAX (15 years). CPXRX (0.28) is less costly to investors than FSMAX (0.04). FSMAX is a more actively managed with annual turnover of: 23.00 vs. CPXRX (16.00). CPXRX (0) and FSMAX (0) have matching initial minimum investment requirements. FSMAX annual gain was more profitable for investors over the last year : 23.68 vs. CPXRX (11.82). FSMAX return over 5 years is better than : 40.14 vs. CPXRX (-4.83).
CPXRXFSMAXCPXRX / FSMAX
Total Expense Ratio0.200.04571%
Annual Report Gross Expense Ratio0.280.04800%
Fund Existence14 years15 years-
Gain YTD12.10516.93771%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets2.51B40.1B6%
Annual Yield % from dividends1.110.50220%
Returns for 1 year11.8223.6850%
Returns for 3 years21.9372.7430%
Returns for 5 years-4.8340.14-12%
Returns for 10 years15.90134.4912%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IGAIX51.350.59
+1.16%
American Funds Intl Gr and Inc F-3
WAMVX4.940.05
+1.02%
Wasatch Micro Cap Value
RUSTX18.850.11
+0.59%
Russell Inv US Strategic Equity M
RTSGX5.740.02
+0.35%
Transamerica Small Cap Growth R6
HFDRX21.870.06
+0.28%
Hartford Schroders US MidCap Opps R3